(CLMT) Calumet Specialty Products - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1314761032
CLMT: Solvents, Waxes, Lubricating Oils, Renewable Fuels, Asphalt, Jet Fuel
Calumet Specialty Products Partners (NASDAQ:CLMT) is a diversified specialty products and renewable fuels company with a strong presence in North America and international markets. Since its founding in 1919, the company has built a reputation for delivering high-quality, customized solutions across various industrial and consumer-facing sectors.
Operating through three distinct segments—Specialty Products and Solutions, Montana/Renewables, and Performance Brands—Calumet offers a broad range of products. The Specialty Products and Solutions segment provides solvents, waxes, and customized lubricating oils, catering to industries requiring precise formulations. The Montana/Renewables segment is a key player in processing renewable feedstocks into bio-based products like renewable diesel and sustainable aviation fuel, alongside conventional refining of Canadian crude oil into fuels and asphalt. The Performance Brands segment, which includes Royal Purple, Bel-Ray, and TruFuel, focuses on high-performance lubricants and fuels for niche markets.
With a market capitalization of $1.422 billion, Calumet trades on the NASDAQ under the ticker symbol CLMT. The company’s financial metrics, including a forward P/E ratio of 11.35 and a price-to-book ratio of 19.32, provide insight into its valuation. Calumet’s diverse operations and strategic focus on renewable energy position it as a significant player in the evolving energy landscape, making it a notable consideration for investors and fund managers interested in the specialty chemicals and renewable fuels sectors.
Additional Sources for CLMT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLMT Stock Overview
Market Cap in USD | 856m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Oil & Gas Refining & Marketing |
IPO / Inception | 2006-01-26 |
CLMT Stock Ratings
Growth Rating | 64.2 |
Fundamental | 7.85 |
Dividend Rating | 11.7 |
Rel. Strength | -22.2 |
Analysts | 4/5 |
Fair Price Momentum | 11.66 USD |
Fair Price DCF | - |
CLMT Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 46.7% |
CLMT Growth Ratios
Growth Correlation 3m | -89.7% |
Growth Correlation 12m | -9.9% |
Growth Correlation 5y | 76.4% |
CAGR 5y | 41.68% |
CAGR/Max DD 5y | 0.67 |
Sharpe Ratio 12m | -0.06 |
Alpha | -42.79 |
Beta | 1.790 |
Volatility | 112.21% |
Current Volume | 802.4k |
Average Volume 20d | 1085.2k |
As of April 29, 2025, the stock is trading at USD 11.08 with a total of 802,367 shares traded.
Over the past week, the price has changed by +20.12%, over one month by -15.84%, over three months by -26.22% and over the past year by -30.87%.
Neither. Based on ValueRay Fundamental Analyses, Calumet Specialty Products is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.85 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLMT as of April 2025 is 11.66. This means that CLMT is currently overvalued and has a potential downside of 5.23%.
Calumet Specialty Products has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CLMT.
- Strong Buy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CLMT Calumet Specialty Products will be worth about 12.8 in April 2026. The stock is currently trading at 11.08. This means that the stock has a potential upside of +15.34%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19.6 | 76.9% |
Analysts Target Price | 24.6 | 122% |
ValueRay Target Price | 12.8 | 15.3% |